Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Precision NanoSystems
Portfolio company

Precision NanoSystems

Details
Region
Prairies and West
Industry sector
Life sciences
Investment year
2019
Fund
Industrial Innovation Venture Fund
Learn More
Investor
Joseph Regan
Joseph Regan

Managing Partner

View profile
About the company

Precision NanoSystems (PNI) provides end-to-end solutions for companies developing medicines in oncology, infectious diseases and rare diseases. PNI’s proprietary technologies include its NanoAssemblr microfluidic-based continuous flow manufacturing platform for the development and manufacture of nanoparticle drug delivery systems, and its lipid nanoparticle delivery technology for RNA medicines. PNI supports its clients with custom research projects through its Formulation Solutions service and clinical implementation through Clinical Solutions. With its lipid nanoparticle delivery system, NanoAssemblr technology and its extensive drug development expertise, PNI’s platform is ushering in the next wave of medicines in infectious diseases, cancer and rare diseases.